News Conference News ESC 2015 ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff September 09, 2015
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Industry News New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology August 20, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
News Industry News Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada July 22, 2015
News Daily News RE-VERSE AD: Dabigatran Antidote Appears Safe, Effective in Interim Analysis June 25, 2015
News Daily News El Posible Riesgo Cardiovascular de los IBP se Mantiene en 2 Nuevos Estudios June 18, 2015
News Daily News ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy April 29, 2015
News Conference News ACC 2015 MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin Todd Neale March 17, 2015
News Daily News ITALIC Published: No Benefit to Long-Term DAPT After Stenting Yael L. Maxwell March 10, 2015
News Daily News Year in Review: Physicians Highlight the Most Important Interventional News of 2014 Todd Neale January 12, 2015
News Daily News Repaso del Año: Los Médicos Señalan las Noticias Más Importantes en Cardiología Intervencionista de 2014 Todd Neale January 12, 2015